CRYSTALLINE OMARIGLIPTIN SALTS
The present invention relates to non-hygroscopic omarigliptin acid addition salts, preferably to non-hygroscopic crystalline omarigliptin acid addition salts such as omarigliptin acid addition salts with an acid selected from the group of hydrochloric acid, fumaric acid, R-mandelic acid, S- mandelic...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LENGAUER, Hannes HOTTER, Andreas |
| description | The present invention relates to non-hygroscopic omarigliptin acid addition salts, preferably to non-hygroscopic crystalline omarigliptin acid addition salts such as omarigliptin acid addition salts with an acid selected from the group of hydrochloric acid, fumaric acid, R-mandelic acid, S- mandelic acid and RS- mandelic acid and to methods for their preparation. In addition, the invention is directed to pharmaceutical compositions comprising an effective amount of an omarigliptin acid addition salt of the present invention and at least one pharmaceutically acceptable excipient. The pharmaceutical compositions of the present invention are suitable for the treatment of type 2 diabetes, obesity and high blood pressure, in particular for the treatment of type 2 diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3181565A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3181565A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3181565A13</originalsourceid><addsrcrecordid>eNrjZJBzDooMDnH08fH0c1Xw93UM8nT38QwI8fRTCHb0CQnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGhhaGpmamjobGRCgBAJSFIUc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE OMARIGLIPTIN SALTS</title><source>esp@cenet</source><creator>LENGAUER, Hannes ; HOTTER, Andreas</creator><creatorcontrib>LENGAUER, Hannes ; HOTTER, Andreas</creatorcontrib><description>The present invention relates to non-hygroscopic omarigliptin acid addition salts, preferably to non-hygroscopic crystalline omarigliptin acid addition salts such as omarigliptin acid addition salts with an acid selected from the group of hydrochloric acid, fumaric acid, R-mandelic acid, S- mandelic acid and RS- mandelic acid and to methods for their preparation. In addition, the invention is directed to pharmaceutical compositions comprising an effective amount of an omarigliptin acid addition salt of the present invention and at least one pharmaceutically acceptable excipient. The pharmaceutical compositions of the present invention are suitable for the treatment of type 2 diabetes, obesity and high blood pressure, in particular for the treatment of type 2 diabetes.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170621&DB=EPODOC&CC=EP&NR=3181565A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170621&DB=EPODOC&CC=EP&NR=3181565A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LENGAUER, Hannes</creatorcontrib><creatorcontrib>HOTTER, Andreas</creatorcontrib><title>CRYSTALLINE OMARIGLIPTIN SALTS</title><description>The present invention relates to non-hygroscopic omarigliptin acid addition salts, preferably to non-hygroscopic crystalline omarigliptin acid addition salts such as omarigliptin acid addition salts with an acid selected from the group of hydrochloric acid, fumaric acid, R-mandelic acid, S- mandelic acid and RS- mandelic acid and to methods for their preparation. In addition, the invention is directed to pharmaceutical compositions comprising an effective amount of an omarigliptin acid addition salt of the present invention and at least one pharmaceutically acceptable excipient. The pharmaceutical compositions of the present invention are suitable for the treatment of type 2 diabetes, obesity and high blood pressure, in particular for the treatment of type 2 diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBzDooMDnH08fH0c1Xw93UM8nT38QwI8fRTCHb0CQnmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGhhaGpmamjobGRCgBAJSFIUc</recordid><startdate>20170621</startdate><enddate>20170621</enddate><creator>LENGAUER, Hannes</creator><creator>HOTTER, Andreas</creator><scope>EVB</scope></search><sort><creationdate>20170621</creationdate><title>CRYSTALLINE OMARIGLIPTIN SALTS</title><author>LENGAUER, Hannes ; HOTTER, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3181565A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LENGAUER, Hannes</creatorcontrib><creatorcontrib>HOTTER, Andreas</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LENGAUER, Hannes</au><au>HOTTER, Andreas</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE OMARIGLIPTIN SALTS</title><date>2017-06-21</date><risdate>2017</risdate><abstract>The present invention relates to non-hygroscopic omarigliptin acid addition salts, preferably to non-hygroscopic crystalline omarigliptin acid addition salts such as omarigliptin acid addition salts with an acid selected from the group of hydrochloric acid, fumaric acid, R-mandelic acid, S- mandelic acid and RS- mandelic acid and to methods for their preparation. In addition, the invention is directed to pharmaceutical compositions comprising an effective amount of an omarigliptin acid addition salt of the present invention and at least one pharmaceutically acceptable excipient. The pharmaceutical compositions of the present invention are suitable for the treatment of type 2 diabetes, obesity and high blood pressure, in particular for the treatment of type 2 diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3181565A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CRYSTALLINE OMARIGLIPTIN SALTS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A28%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LENGAUER,%20Hannes&rft.date=2017-06-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3181565A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |